Fábio Gomes

4.7k total citations
57 papers, 686 citations indexed

About

Fábio Gomes is a scholar working on Oncology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fábio Gomes has authored 57 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 21 papers in Geriatrics and Gerontology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fábio Gomes's work include Frailty in Older Adults (21 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lung Cancer Treatments and Mutations (16 papers). Fábio Gomes is often cited by papers focused on Frailty in Older Adults (21 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lung Cancer Treatments and Mutations (16 papers). Fábio Gomes collaborates with scholars based in United Kingdom, Italy and United States. Fábio Gomes's co-authors include Paul Lorigan, Fiona Blackhall, Raffaele Califano, Janelle Yorke, Élisabeth Carola, Florian Strasser, Pascale Dielenseger, Susan Knox, Florian Scotté and Paolo Bossi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Fábio Gomes

54 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fábio Gomes United Kingdom 16 414 207 142 84 83 57 686
Tira J. Tan Singapore 15 399 1.0× 139 0.7× 24 0.2× 28 0.3× 245 3.0× 56 752
Lada Krilov United States 8 300 0.7× 152 0.7× 16 0.1× 56 0.7× 220 2.7× 9 708
Zahra Pournamdar Iran 8 375 0.9× 120 0.6× 12 0.1× 59 0.7× 251 3.0× 12 956
Andreas Polychronis United Kingdom 13 613 1.5× 339 1.6× 20 0.1× 92 1.1× 280 3.4× 33 1.1k
Andrea Pujol Nicolas France 7 395 1.0× 160 0.8× 48 0.3× 18 0.2× 127 1.5× 11 659
Nadya Dimitrova Italy 13 409 1.0× 144 0.7× 10 0.1× 78 0.9× 152 1.8× 39 804
Sonalee Shah United States 11 165 0.4× 435 2.1× 17 0.1× 61 0.7× 354 4.3× 20 905
Matthew C. Foster United States 14 268 0.6× 48 0.2× 23 0.2× 65 0.8× 130 1.6× 71 642
Selena Z. Kuo United States 16 228 0.6× 61 0.3× 33 0.2× 26 0.3× 415 5.0× 24 838
Nicholas Nicholson Italy 7 231 0.6× 117 0.6× 9 0.1× 38 0.5× 115 1.4× 24 522

Countries citing papers authored by Fábio Gomes

Since Specialization
Citations

This map shows the geographic impact of Fábio Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fábio Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fábio Gomes more than expected).

Fields of papers citing papers by Fábio Gomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fábio Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fábio Gomes. The network helps show where Fábio Gomes may publish in the future.

Co-authorship network of co-authors of Fábio Gomes

This figure shows the co-authorship network connecting the top 25 collaborators of Fábio Gomes. A scholar is included among the top collaborators of Fábio Gomes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fábio Gomes. Fábio Gomes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neuendorff, Nina Rosa, Jan Leipe, Christine Sam, et al.. (2025). Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG). The Lancet Oncology. 26(2). e90–e102. 6 indexed citations
2.
Wong, David, Fábio Gomes, Corinne Faivre‐Finn, et al.. (2024). Exploring the value of routinely collected data on EQ-5D-5L and other electronic patient-reported outcome measures as prognostic factors in adults with advanced non-small cell lung cancer receiving immunotherapy. SHILAP Revista de lepidopterología. 3(1). e000158–e000158. 2 indexed citations
3.
4.
5.
Abravan, Azadeh, Corinne Faivre‐Finn, Fábio Gomes, Marcel van Herk, & Gareth Price. (2024). Comorbidity in patients with cancer treated at The Christie. British Journal of Cancer. 131(8). 1279–1289. 3 indexed citations
6.
7.
8.
Behrouzi, Roya, Alessio Signori, Judith Cave, et al.. (2023). Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. Frontiers in Oncology. 13. 6 indexed citations
9.
Behrouzi, Roya, Alessio Signori, Judith Cave, et al.. (2023). The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. International Journal of Molecular Sciences. 24(2). 1746–1746. 3 indexed citations
10.
Wang, Tianxiao, David Wong, Fábio Gomes, et al.. (2022). Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review. BMC Cancer. 22(1). 1076–1076. 8 indexed citations
11.
Haase, Kristen R., Bonnie Leung, Virginia Sun, & Fábio Gomes. (2022). Assessing psychological health and social support in older adults with cancer, a how-to guide – A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative. Journal of Geriatric Oncology. 13(7). 1050–1053. 3 indexed citations
12.
Blackhall, Fiona, et al.. (2022). The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer. Oncology and Therapy. 10(2). 481–491. 5 indexed citations
13.
Presley, Carolyn J., Fábio Gomes, Christin E. Burd, Ravindran Kanesvaran, & Melisa L. Wong. (2021). Immunotherapy in Older Adults With Cancer. Journal of Clinical Oncology. 39(19). 2115–2127. 45 indexed citations
14.
Gomes, Fábio, Corinne Faivre‐Finn, Hitesh Mistry, et al.. (2021). Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial. Lung Cancer. 153. 165–170. 8 indexed citations
15.
Tivey, Ann, Rohan Shotton, Rebecca Lee, et al.. (2020). 1722P Longitudinal analysis of biochemical and haematological features of cancer patients with COVID-19. Annals of Oncology. 31. S1011–S1011. 1 indexed citations
16.
Desideri, Isacco, Sophie Pilleron, Nicolò Matteo Luca Battisti, et al.. (2020). Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective. Journal of Geriatric Oncology. 11(7). 1175–1181. 21 indexed citations
17.
Gomes, Fábio, Katie Baker, Laura Cove-Smith, et al.. (2019). MA19.09 Assessing Clinical Frailty in Advanced Lung Cancer Patients - An Opportunity to Improve Patient Outcomes?. Journal of Thoracic Oncology. 14(10). S329–S329. 3 indexed citations
18.
Califano, Raffaele, Fábio Gomes, Christoph Ackermann, et al.. (2019). Immune checkpoint blockade for non–small cell lung cancer: What is the role in the special populations?. European Journal of Cancer. 125. 1–11. 29 indexed citations
19.
Gomes, Fábio, Rebecca Tay, Jaseela Chiramel, & Raffaele Califano. (2018). The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer. Drugs & Aging. 35(9). 819–834. 18 indexed citations
20.
Gomes, Fábio, Corinne Faivre‐Finn, Fabiola Fernández‐Gutiérrez, et al.. (2017). Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial. Annals of Oncology. 28. ii61–ii61. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tira J. Tan Breakdown of academic impact, for papers by Lada Krilov Breakdown of academic impact, for papers by Zahra Pournamdar Breakdown of academic impact, for papers by Andreas Polychronis Breakdown of academic impact, for papers by Andrea Pujol Nicolas Breakdown of academic impact, for papers by Nadya Dimitrova Breakdown of academic impact, for papers by Sonalee Shah Breakdown of academic impact, for papers by Matthew C. Foster Breakdown of academic impact, for papers by Selena Z. Kuo Breakdown of academic impact, for papers by Nicholas Nicholson
Rankless by CCL
2026